Richard I. Eisenstadt - Dec 29, 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Signature
/s/ Richard I. Eisenstadt
Stock symbol
ALT
Transactions as of
Dec 29, 2023
Transactions value $
-$34,245
Form type
4
Date filed
1/2/2024, 06:00 PM
Previous filing
Aug 2, 2023
Next filing
Jan 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Options Exercise $0 +12.5K +52.44% $0.00 36.3K Dec 29, 2023 Direct F1
transaction ALT Common Stock, par value $0.0001 Tax liability -$34.2K -3.04K -8.38% $11.25 33.3K Dec 29, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Restricted Stock Units Options Exercise $0 -12.5K -33.33% $0.00 25K Dec 29, 2023 Common Stock, par value $0.0001 12.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
F2 Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
F3 The RSUs become vested and exercisable over four (4) years with 25% of the shares vesting on December 31, 2022, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.